Dwight Moxie Net Worth & Insider Trades
Dwight Moxie - SVP, Revance Therapeutics, Inc
What is Dwight Moxie's Net Worth?
The current estimated net worth of Revance Therapeutics, Inc's SVP, Dwight Moxie, is estimated to be about $1M . Dwight Moxie owns about 31,694 units of Revance Therapeutics, Inc common stock. In the last 2 years at Revance Therapeutics, Inc, Dwight Moxie has sold an estimated value of $615.12K worth.
What is Dwight Moxie's Past Insider Trading?
Dwight Moxie's largest sale order was 11,000 units , worth over $297.8K on September 16, 2022. In total, Dwight Moxie has made about 8 transactions over 2 years of their time at Revance Therapeutics, Inc. Dwight Moxie usually trades in February, with the busiest year in 2022 and 2021.
Dwight Moxie
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
What was Dwight Moxie's Salary in 2020?
As SVP of Revance Therapeutics, Inc, Dwight Moxie has a total base salary of $370,104 . Dwight Moxie received compensation valued at about $4,519,508 in 2020 after becoming SVP. The vast majority of their compensation came in the form of a bonus of $125,000 , stock awards of $1,309,383 , option awards of $2,579,240 , other earnings, plans or compensations of $125,426 , and other compensation of $10,356 .
What is Dwight Moxie's' Mailing Address?
- Mailing address is 7555 Gateway Boulevard Newark CA 94560 CA
Revance Therapeutics, Inc Executive Compensation
Name |
Year
|
Salary
|
Bonus
|
Stock Awards
|
Option Awards
|
Other Earnings Plans or Compensations
|
Other Compensation
|
Total
|
|---|---|---|---|---|---|---|---|---|
| Mark J. Foley | 2020 | $650,000 | - | $7,794,350 | - | $328,331 | $8,255 | $8,780,936 |
| Mark J. Foley | 2019 | $189,764 | $150,000 | $11,728,370 | $5,112,573 | - | $9,723 | $17,190,430 |
| Tobin C. Schilke | 2020 | $421,375 | - | $1,131,345 | $1,273,662 | $143,186 | $11,531 | $2,981,099 |
| Tobin C. Schilke | 2019 | $407,126 | $25,000 | $86,150 | $299,781 | $178,123 | $11,078 | $1,007,258 |
| Tobin C. Schilke | 2018 | $64,644 | $25,000 | $449,280 | $1,434,350 | - | $233 | $1,973,507 |
| Abhay Joshi, Ph.D. | 2020 | $514,608 | - | $1,405,850 | $1,913,759 | $213,726 | $11,731 | $4,059,674 |
| Abhay Joshi, Ph.D. | 2019 | $485,479 | - | $271,373 | $939,314 | $204,211 | $9,520 | $1,909,897 |
| Abhay Joshi, Ph.D. | 2018 | $469,062 | - | $342,513 | $1,192,465 | $232,186 | $9,210 | $2,245,436 |
| Dustin Sjuts | 2020 | $415,000 | - | $1,294,250 | $1,306,320 | $141,020 | $66,242 | $3,222,832 |
| Dustin Sjuts | 2019 | $378,333 | $50,000 | $43,075 | $99,927 | $183,902 | $45,786 | $801,023 |
| Dwight Moxie | 2020 | $370,104 | $125,000 | $1,309,383 | $2,579,240 | $125,426 | $10,356 | $4,519,508 |
| No matching records found | ||||||||
Source: https://www.sec.gov/Archives/edgar/data/1479290/000147929021000089/rvncfy20proxystatementdef1.htm
What are Revance Therapeutics, Inc's Past Insider Trades?
Revance Therapeutics, Inc's most recent insider trade came on January 23, 2023 by Tobin Schilke who sold 1,000 units worth $31K . In the last 9 years, insiders at Revance Therapeutics, Inc have sold an estimated value of $31.65M and bought an estimated value of $8.66M worth of shares. Insider trading is most common in May, with the busiest year in 2021. The most active traders at the company are Daniel Browne, CEO and President, Curtis Ruegg, EVP, and Lauren Silvernail, CFO & CBO .
Revance Therapeutics, Inc. Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||